Abstract
Summary
According to our LPI (LP Information) latest study, the global Nocturia market size was valued at US$ 2090.1 million in 2023. With growing demand in downstream market, the Nocturia is forecast to a readjusted size of US$ 3407.2 million by 2030 with a CAGR of 7.2% during review period. _x000D_
The research report highlights the growth potential of the global Nocturia market. Nocturia are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Nocturia. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Nocturia market._x000D_
Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria._x000D_
Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%._x000D_
Key Features:_x000D_
The report on Nocturia market reflects various aspects and provide valuable insights into the industry._x000D_
Market Size and Growth: The research report provide an overview of the current size and growth of the Nocturia market. It may include historical data, market segmentation by Type (e.g., Desmopressin, Anticholinergic Drugs), and regional breakdowns._x000D_
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Nocturia market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs._x000D_
Competitive Landscape: The research report provides analysis of the competitive landscape within the Nocturia market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market._x000D_
Technological Developments: The research report can delve into the latest technological developments in the Nocturia industry. This include advancements in Nocturia technology, Nocturia new entrants, Nocturia new investment, and other innovations that are shaping the future of Nocturia._x000D_
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Nocturia market. It includes factors influencing customer ' purchasing decisions, preferences for Nocturia product._x000D_
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Nocturia market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Nocturia market. The report also evaluates the effectiveness of these policies in driving market growth._x000D_
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Nocturia market. _x000D_
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Nocturia industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments._x000D_
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Nocturia market._x000D_
Market Segmentation:_x000D_
Nocturia market is split by Type and by Sale Channels. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Sale Channels in terms of value._x000D_
Segmentation by type_x000D_
Desmopressin_x000D_
Anticholinergic Drugs_x000D_
Alpha Blockers_x000D_
Diuretics_x000D_
Others_x000D_
Segmentation by sale channels_x000D_
Hospital Pharmacies_x000D_
Retail Pharmacies_x000D_
Online Pharmacies_x000D_
This report also splits the market by region:_x000D_
Americas_x000D_
United States_x000D_
Canada_x000D_
Mexico_x000D_
Brazil_x000D_
APAC_x000D_
China_x000D_
Japan_x000D_
Korea_x000D_
Southeast Asia_x000D_
India_x000D_
Australia_x000D_
Europe_x000D_
Germany_x000D_
France_x000D_
UK_x000D_
Italy_x000D_
Russia_x000D_
Middle East & Africa_x000D_
Egypt_x000D_
South Africa_x000D_
Israel_x000D_
Turkey_x000D_
GCC Countries_x000D_
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration._x000D_
Astellas Pharma_x000D_
Allergan_x000D_
Ferring Pharmaceuticals_x000D_
Eli Lilly_x000D_
GlaxoSmithKline_x000D_
Sanofi_x000D_
Pfizer_x000D_
Abbott_x000D_
Teva_x000D_
Mylan_x000D_
Johnson & Johnson_x000D_
Hainan Zhonghe Pharmaceutical_x000D_
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nocturia Market Size 2019-2030
2.1.2 Nocturia Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Nocturia Segment by Type
2.2.1 Desmopressin
2.2.2 Anticholinergic Drugs
2.2.3 Alpha Blockers
2.2.4 Diuretics
2.2.5 Others
2.3 Nocturia Market Size by Type
2.3.1 Nocturia Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Nocturia Market Size Market Share by Type (2019-2024)
2.4 Nocturia Segment by Sale Channels
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Nocturia Market Size by Sale Channels
2.5.1 Nocturia Market Size CAGR by Sale Channels (2019 VS 2023 VS 2030)
2.5.2 Global Nocturia Market Size Market Share by Sale Channels (2019-2024)
3 Nocturia Market Size by Player
3.1 Nocturia Market Size Market Share by Players
3.1.1 Global Nocturia Revenue by Players (2019-2024)
3.1.2 Global Nocturia Revenue Market Share by Players (2019-2024)
3.2 Global Nocturia Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nocturia by Regions
4.1 Nocturia Market Size by Regions (2019-2024)
4.2 Americas Nocturia Market Size Growth (2019-2024)
4.3 APAC Nocturia Market Size Growth (2019-2024)
4.4 Europe Nocturia Market Size Growth (2019-2024)
4.5 Middle East & Africa Nocturia Market Size Growth (2019-2024)
5 Americas
5.1 Americas Nocturia Market Size by Country (2019-2024)
5.2 Americas Nocturia Market Size by Type (2019-2024)
5.3 Americas Nocturia Market Size by Sale Channels (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nocturia Market Size by Region (2019-2024)
6.2 APAC Nocturia Market Size by Type (2019-2024)
6.3 APAC Nocturia Market Size by Sale Channels (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nocturia by Country (2019-2024)
7.2 Europe Nocturia Market Size by Type (2019-2024)
7.3 Europe Nocturia Market Size by Sale Channels (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nocturia by Region (2019-2024)
8.2 Middle East & Africa Nocturia Market Size by Type (2019-2024)
8.3 Middle East & Africa Nocturia Market Size by Sale Channels (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nocturia Market Forecast
10.1 Global Nocturia Forecast by Regions (2025-2030)
10.1.1 Global Nocturia Forecast by Regions (2025-2030)
10.1.2 Americas Nocturia Forecast
10.1.3 APAC Nocturia Forecast
10.1.4 Europe Nocturia Forecast
10.1.5 Middle East & Africa Nocturia Forecast
10.2 Americas Nocturia Forecast by Country (2025-2030)
10.2.1 United States Nocturia Market Forecast
10.2.2 Canada Nocturia Market Forecast
10.2.3 Mexico Nocturia Market Forecast
10.2.4 Brazil Nocturia Market Forecast
10.3 APAC Nocturia Forecast by Region (2025-2030)
10.3.1 China Nocturia Market Forecast
10.3.2 Japan Nocturia Market Forecast
10.3.3 Korea Nocturia Market Forecast
10.3.4 Southeast Asia Nocturia Market Forecast
10.3.5 India Nocturia Market Forecast
10.3.6 Australia Nocturia Market Forecast
10.4 Europe Nocturia Forecast by Country (2025-2030)
10.4.1 Germany Nocturia Market Forecast
10.4.2 France Nocturia Market Forecast
10.4.3 UK Nocturia Market Forecast
10.4.4 Italy Nocturia Market Forecast
10.4.5 Russia Nocturia Market Forecast
10.5 Middle East & Africa Nocturia Forecast by Region (2025-2030)
10.5.1 Egypt Nocturia Market Forecast
10.5.2 South Africa Nocturia Market Forecast
10.5.3 Israel Nocturia Market Forecast
10.5.4 Turkey Nocturia Market Forecast
10.5.5 GCC Countries Nocturia Market Forecast
10.6 Global Nocturia Forecast by Type (2025-2030)
10.7 Global Nocturia Forecast by Sale Channels (2025-2030)
11 Key Players Analysis
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Information
11.1.2 Astellas Pharma Nocturia Product Offered
11.1.3 Astellas Pharma Nocturia Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Astellas Pharma Main Business Overview
11.1.5 Astellas Pharma Latest Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Nocturia Product Offered
11.2.3 Allergan Nocturia Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Allergan Main Business Overview
11.2.5 Allergan Latest Developments
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Information
11.3.2 Ferring Pharmaceuticals Nocturia Product Offered
11.3.3 Ferring Pharmaceuticals Nocturia Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Ferring Pharmaceuticals Main Business Overview
11.3.5 Ferring Pharmaceuticals Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Nocturia Product Offered
11.4.3 Eli Lilly Nocturia Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Nocturia Product Offered
11.5.3 GlaxoSmithKline Nocturia Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Nocturia Product Offered
11.6.3 Sanofi Nocturia Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Nocturia Product Offered
11.7.3 Pfizer Nocturia Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Pfizer Main Business Overview
11.7.5 Pfizer Latest Developments
11.8 Abbott
11.8.1 Abbott Company Information
11.8.2 Abbott Nocturia Product Offered
11.8.3 Abbott Nocturia Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Abbott Main Business Overview
11.8.5 Abbott Latest Developments
11.9 Teva
11.9.1 Teva Company Information
11.9.2 Teva Nocturia Product Offered
11.9.3 Teva Nocturia Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Teva Main Business Overview
11.9.5 Teva Latest Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Nocturia Product Offered
11.10.3 Mylan Nocturia Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Mylan Main Business Overview
11.10.5 Mylan Latest Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Information
11.11.2 Johnson & Johnson Nocturia Product Offered
11.11.3 Johnson & Johnson Nocturia Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Johnson & Johnson Main Business Overview
11.11.5 Johnson & Johnson Latest Developments
11.12 Hainan Zhonghe Pharmaceutical
11.12.1 Hainan Zhonghe Pharmaceutical Company Information
11.12.2 Hainan Zhonghe Pharmaceutical Nocturia Product Offered
11.12.3 Hainan Zhonghe Pharmaceutical Nocturia Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Hainan Zhonghe Pharmaceutical Main Business Overview
11.12.5 Hainan Zhonghe Pharmaceutical Latest Developments
12 Research Findings and Conclusion